Tag: Flu
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots
Primary composite reactogenicity outcome noninferior for those receiving both vaccines simultaneously
FDA Proposes Ban on a ‘Useless’ Decongestant, Phenylephrine
Flu Vaccine Coverage 80.7 Percent for Health Workers in Acute Care Hospitals
Coverage lower among health care personnel at nursing homes, while coverage for COVID-19 2023-24 vaccine was much lower
Flu-Linked Hospitalization Rates Vary Across Seasons, Highest in Adults 65+
For patients hospitalized with influenza, prevalence of at least one underlying medical condition increased with age
Letter Nudges Increase Likelihood of Flu Vaccination for Adults With Chronic Diseases
Influenza vaccination rates higher for those receiving one of six intervention letters versus usual care
Flu Vaccine Efficacy Examined in Southern Hemisphere Countries
Adjusted vaccine efficacy was 36.5 percent against the predominant subtype A(H3N2) and 37.1 percent against A(H1N1)pdm09
Most Americans Won’t Get Vaccinated as Flu, COVID Season Looms: Survey
Maternal Influenza Infection in Pregnancy Tied to Seizures in Offspring
Significantly increased risk for seizures and febrile convulsions, but not epilepsy, observed in offspring
No Perinatal Risks Seen With Influenza Vaccination in Successive Pregnancies
No increased risk noted for prespecified outcomes, including preeclampsia or eclampsia, placental abruption, preterm birth, SGA
FDA Approves First Flu Vaccine That Can Be Self-Administered at Home
A prescription will still be needed to get FluMist, and patients must be 18 years or older to self-administer
